Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 Years.

Tartof, Sara Y; Frankland, Timothy B; Slezak, Jeff M; Puzniak, Laura; Ackerson, Bradley K; Jodar, Luis; McLaughlin, John M

Tartof, Sara Y; Frankland, Timothy B; Slezak, Jeff M; Puzniak, Laura; Ackerson, Bradley K; Jodar, Luis; McLaughlin, John M.

Afiliación

Tartof SY; Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena.
Frankland TB; Kaiser Permanente Hawai'i Center for Integrated Health Care Research, Honolulu, Hawai'i.
Slezak JM; Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena.
Puzniak L; Pfizer Inc, Collegeville, Pennsylvania.
Ackerson BK; Southern California Permanente Medical Group, Harbor City.
Jodar L; Pfizer Inc, Collegeville, Pennsylvania.
McLaughlin JM; Pfizer Inc, Collegeville, Pennsylvania.

JAMA ; 330(13): 1282-1284, 2023 10 03.

Article en En | MEDLINE | ID: mdl-37712905

This study examines the association of the receipt of wild-type BNT162b2 vaccine with medically attended COVID-19 outcomes among children younger than 5 years in the US.

Asunto(s)

Vacuna BNT162; COVID-19; Humanos; Vacuna BNT162/uso terapéutico; COVID-19/epidemiología; COVID-19/prevención & control; Atención Ambulatoria/estadística & datos numéricos; Estados Unidos/epidemiología; Preescolar; Vacunación/estadística & datos numéricos; Factores de Edad

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Límite: Child, preschool / Humans País/Región como asunto: America do norte Idioma: En Revista: JAMA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google